{"transactions":[{"id":783040,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-12T20:22:11.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":3851,"source":{"system":"sec-edgar","filing":"0001100682-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000068/form4.xml","form_type":"4"}},{"id":948761,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-01-06T21:18:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1962,"derivative":{"exercise_price":772.76,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0001423419-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000142341926000001/edgardoc.xml","form_type":"4"}},{"id":948760,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:18:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":775,"source":{"system":"sec-edgar","filing":"0001423419-26-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000142341926000001/edgardoc.xml","form_type":"4"}},{"id":1135853,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-23T20:27:57.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":2076,"price":134.98,"value":280218.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock options become exercisable upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2076,"derivative":{"exercise_price":134.98,"exercise_date":"2026-05-21","expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":2076},"source":{"system":"sec-edgar","filing":"0001127602-25-015491","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015491/form4.xml","form_type":"4"}},{"id":1135852,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-23T20:27:57.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":946,"price":134.98,"value":127691.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2413,"source":{"system":"sec-edgar","filing":"0001127602-25-015491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015491/form4.xml","form_type":"4"}},{"id":1312121,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-06T21:13:03.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1958,"derivative":{"exercise_price":719.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1958},"source":{"system":"sec-edgar","filing":"0001968202-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000011/edgardoc.xml","form_type":"4"}},{"id":1312120,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:13:03.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":620,"source":{"system":"sec-edgar","filing":"0001968202-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000011/edgardoc.xml","form_type":"4"}},{"id":1516345,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-15T21:47:36.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":1311,"price":228.41,"value":299445.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1311,"derivative":{"exercise_price":228.41,"exercise_date":"2025-05-13","expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":1311},"source":{"system":"sec-edgar","filing":"0001127602-24-015529","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224015529/form4.xml","form_type":"4"}},{"id":1516344,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-15T21:47:36.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":559,"price":228.41,"value":127681.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1467,"source":{"system":"sec-edgar","filing":"0001127602-24-015529","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224015529/form4.xml","form_type":"4"}},{"id":1689473,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:15:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1607,"derivative":{"exercise_price":888.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":1607},"source":{"system":"sec-edgar","filing":"0001883850-24-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000001/edgardoc.xml","form_type":"4"}},{"id":1689472,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:15:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":454,"source":{"system":"sec-edgar","filing":"0001883850-24-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000001/edgardoc.xml","form_type":"4"}},{"id":1889722,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-17T19:24:05.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":1669,"price":192.36,"value":321048.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1669,"derivative":{"exercise_price":192.36,"exercise_date":"2024-05-15","expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":1669},"source":{"system":"sec-edgar","filing":"0001127602-23-015868","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015868/form4.xml","form_type":"4"}},{"id":1889721,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-17T19:24:05.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":908,"source":{"system":"sec-edgar","filing":"0001127602-23-015868","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015868/form4.xml","form_type":"4"}},{"id":2064227,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T21:14:01.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":477,"derivative":{"exercise_price":725.89,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":477},"source":{"system":"sec-edgar","filing":"0001883850-23-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000011/edgardoc.xml","form_type":"4"}},{"id":2064226,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:14:01.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":40,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":319,"source":{"system":"sec-edgar","filing":"0001883850-23-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000011/edgardoc.xml","form_type":"4"}},{"id":2069135,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-05T02:35:48.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":592,"price":218.4,"value":129292.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options become exercisable 1/03/2024."}],"balance_after":592,"derivative":{"exercise_price":218.4,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":592},"source":{"system":"sec-edgar","filing":"0001127602-23-000743","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223000743/form4.xml","form_type":"4"}},{"id":2069134,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-05T02:35:48.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 244 unvested restricted stock units that vest on 1/03/2024."}],"balance_after":244,"source":{"system":"sec-edgar","filing":"0001127602-23-000743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223000743/form4.xml","form_type":"4"}},{"id":2142991,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-10-05T20:11:52.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":3216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":3216,"derivative":{"exercise_price":715.56,"expiration_date":"2032-10-03","underlying":"Common Stock","underlying_shares":3216},"source":{"system":"sec-edgar","filing":"0001104659-22-106311","document":"tm2226377-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465922106311/tm2226377-2_4seq1.xml","form_type":"4"}},{"id":2142990,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T20:11:52.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":279,"source":{"system":"sec-edgar","filing":"0001104659-22-106311","document":"tm2226377-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465922106311/tm2226377-2_4seq1.xml","form_type":"4"}},{"id":128343,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2018-05-29T21:33:09.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":3130.8174,"price":59.09,"value":185000.000166,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":31809.8934,"derivative":{"underlying":"Common Stock","underlying_shares":3130.8174},"source":{"system":"sec-edgar","filing":"0001225208-18-009927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520818009927/doc4.xml","form_type":"4"}},{"id":3933284,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-16T00:31:37.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This grant was made in lieu of director service fees for the term commencing May 8, 2018.  The restricted stock units vest upon the earlier of 5/14/2019 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":17586,"source":{"system":"sec-edgar","filing":"0001127602-18-017564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760218017564/form4.xml","form_type":"4"}},{"id":3933283,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-16T00:31:37.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":2004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":16933,"source":{"system":"sec-edgar","filing":"0001127602-18-017564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760218017564/form4.xml","form_type":"4"}},{"id":140034,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2017-05-30T21:33:43.000Z","date":"2017-05-26","kind":"grant","acquired":true,"shares":2618.6075,"price":64.92,"value":169999.9989,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":27773.1335,"derivative":{"underlying":"Common Stock","underlying_shares":2618.6075},"source":{"system":"sec-edgar","filing":"0001225208-17-010559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520817010559/doc4.xml","form_type":"4"}},{"id":4318767,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-16T15:05:38.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This grant was made in lieu of director services fees for the term commencing May 9, 2017.  The restricted stock units vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":14929,"source":{"system":"sec-edgar","filing":"0001127602-17-018192","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760217018192/form4.xml","form_type":"4"}},{"id":4318766,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-16T15:05:38.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":2436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 2,436 unvested restricted stock units that vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":14136,"source":{"system":"sec-edgar","filing":"0001127602-17-018192","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760217018192/form4.xml","form_type":"4"}},{"id":152103,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2016-05-31T19:57:06.000Z","date":"2016-05-27","kind":"grant","acquired":true,"shares":3009.915,"price":56.48,"value":169999.9992,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":24408.591,"derivative":{"underlying":"Common Stock","underlying_shares":3009.915},"source":{"system":"sec-edgar","filing":"0001225208-16-034173","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520816034173/doc4.xml","form_type":"4"}},{"id":163530,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2015-06-01T18:50:05.000Z","date":"2015-05-29","kind":"grant","acquired":true,"shares":2463.4587,"price":60.89,"value":150000.000243,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":20686.6487,"derivative":{"underlying":"Common Stock","underlying_shares":2463.4587},"source":{"system":"sec-edgar","filing":"0001225208-15-013057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520815013057/doc4.xml","form_type":"4"}},{"id":173159,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2014-06-03T17:02:24.000Z","date":"2014-05-30","kind":"grant","acquired":true,"shares":2592.4646,"price":57.86,"value":150000.001756,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":17684.4086,"derivative":{"underlying":"Common Stock","underlying_shares":2592.4646},"source":{"system":"sec-edgar","filing":"0001225208-14-014286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520814014286/doc4.xml","form_type":"4"}},{"id":183668,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2013-06-03T19:07:48.000Z","date":"2013-05-31","kind":"grant","acquired":true,"shares":3211.9914,"price":46.7,"value":149999.99838,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":14577.1354,"derivative":{"underlying":"Common Stock","underlying_shares":3211.9914},"source":{"system":"sec-edgar","filing":"0001225208-13-013655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520813013655/doc4.xml","form_type":"4"}},{"id":193172,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2012-05-29T19:22:30.000Z","date":"2012-05-25","kind":"grant","acquired":true,"shares":3994.6738,"price":37.55,"value":150000.00119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":10935.0298,"derivative":{"underlying":"Common Stock","underlying_shares":3994.6738},"source":{"system":"sec-edgar","filing":"0001225208-12-013304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520812013304/doc4.xml","form_type":"4"}},{"id":201728,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2011-05-31T14:46:03.000Z","date":"2011-05-27","kind":"grant","acquired":true,"shares":4142.5021,"price":36.21,"value":150000.001041,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":6641.0541,"derivative":{"underlying":"Common Stock","underlying_shares":4142.5021},"source":{"system":"sec-edgar","filing":"0001225208-11-015344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520811015344/doc4.xml","form_type":"4"}},{"id":212517,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2010-08-06T15:01:01.000Z","date":"2010-08-04","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning August 4, 2011."}],"balance_after":5000,"derivative":{"exercise_price":35.19,"exercise_date":"2011-08-04","expiration_date":"2020-08-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-10-018709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520810018709/doc4.xml","form_type":"4"}},{"id":213524,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2010-06-01T20:03:17.000Z","date":"2010-05-28","kind":"grant","acquired":true,"shares":1632.5319,"price":33.69,"value":54999.999711,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":2395.0709,"derivative":{"underlying":"Common Stock","underlying_shares":1632.5319},"source":{"system":"sec-edgar","filing":"0001225208-10-014305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520810014305/doc4.xml","form_type":"4"}},{"id":218538,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2009-12-10T20:14:04.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":747.2123,"price":30.67,"value":22917.001241,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."}],"balance_after":747.2123,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":747.2123},"source":{"system":"sec-edgar","filing":"0001225208-09-024286","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809024286/doc4a.xml","form_type":"4/A","original_submission_date":"2009-11-05"}},{"id":218537,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2009-12-10T20:14:04.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":5814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The line item is not new or revised, but was reported in error, and the purpose of this amendment is to delete the specified item."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (\"Merger Agreement\") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, (\"New Merck\") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the \"Transactions\"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash.  Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The line item is not new or revised, but was reported in error, and the purpose of this amendment is to delete the specified item."}],"balance_after":5814,"source":{"system":"sec-edgar","filing":"0001225208-09-024286","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809024286/doc4a.xml","form_type":"4/A","original_submission_date":"2009-11-05"}},{"id":219881,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2009-11-06T02:53:24.000Z","date":"2009-11-03","kind":"disposition_to_issuer","acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (\"Merger Agreement\") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, (\"New Merck\") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the \"Transactions\"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash.  Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement."}],"balance_after":3352,"source":{"system":"sec-edgar","filing":"0001225208-09-021812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021812/doc4.xml","form_type":"4"}},{"id":219880,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2009-11-06T02:53:24.000Z","date":"2009-11-03","kind":"grant","acquired":true,"shares":5814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (\"Merger Agreement\") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, (\"New Merck\") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the \"Transactions\"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash.  Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement."}],"balance_after":5814,"source":{"system":"sec-edgar","filing":"0001225208-09-021812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520809021812/doc4.xml","form_type":"4"}},{"id":224360,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2009-06-02T16:54:26.000Z","date":"2009-06-01","kind":"grant","acquired":true,"shares":1567,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired pursuant to the Directors Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable."}],"balance_after":5814,"source":{"system":"sec-edgar","filing":"0000310158-09-000079","document":"tho742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015809000079/tho742.xml","form_type":"4"}},{"id":228034,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2008-12-01T22:57:30.000Z","date":"2008-12-01","kind":"grant","acquired":true,"shares":2567,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired pursuant to the Directors Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable."}],"balance_after":4247,"source":{"system":"sec-edgar","filing":"0000310158-08-000103","document":"tho693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015808000103/tho693.xml","form_type":"4"}},{"id":233211,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":12116,"kind":"person","name":"Thompson Craig B.","position":1,"cik":"0001423419","reported_name":"Thompson Craig B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2008-05-30T21:50:18.000Z","date":"2008-05-30","kind":"grant","acquired":true,"shares":1680,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired pursuant to the Directors Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable."}],"balance_after":1680,"source":{"system":"sec-edgar","filing":"0000310158-08-000072","document":"tho679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015808000072/tho679.xml","form_type":"4"}}]}